Matthew Stanton, CHIEF SCIENTIFIC OFFICER at Generation Bio Co. (GBIO), sold 20,800 shares at $34.76 ($720K) on 2021-02-10, disclosed to the SEC on 2021-02-12.
Open-market sale of $720k GBIO by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.59 | 2,629 | $88K | 12.3% |
| 2 | $33.59 | 2,629 | $88K | 12.3% |
| 3 | $34.76 | 6,030 | $210K | 29.1% |
| 4 | $34.76 | 6,030 | $210K | 29.1% |
| 5 | $35.58 | 1,741 | $62K | 8.6% |
| 6 | $35.58 | 1,741 |
| $62K |
| 8.6% |
| Total | $34.60 avg | 20,800 | $720K | 100% |
| Filing → |
| GBIO | SELL | 2021-08-25 | $38K | — | Filing → |
| GBIO | SELL | 2021-08-11 | $34K | — | Filing → |
| GBIO | SELL | 2021-07-14 | $75K | — | Filing → |